Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers
NCT05234736Phase 2Completed
- Sponsor
- Caliway Biopharmaceuticals
- Start
- Feb 2022
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CBL-514 in subcutaneous fat, sponsored by Caliway Biopharmaceuticals. Started Feb 2022; status: completed.
02
Drugs
CBL-514
03
Conditions
subcutaneous fat
Beyond the preview
Go deeper on NCT05234736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05234736.